Advertisement
Trendy charred food: Is it worth the risk?

Trendy charred food: Is it worth the risk?

By Modern Healthcare  |  February 04, 2017

Charred food may be one of the latest fads at fashionable restaurants—at least according to the New York Times food section—but there seems to be a dark side to this trend.

Data Points: Cancer's toll by race and geography

Data Points: Cancer's toll by race and geography

By Modern Healthcare  |  January 28, 2017

The U.S. cancer mortality rate, in steady decline for over three decades, still takes a higher toll on African Americans. Regional disparities persist, too, with some areas of the country seeing worsening cancer mortality rates.

Where you live could be a matter of life or death if you get cancer

By Steven Ross Johnson  |  January 24, 2017

Cancer deaths have declined in the U.S. over the past three decades, but mortality rates can vary greatly depending on the county where you live. Researchers say that information could better inform treatment and prevention efforts in certain communities.

Drugmaker announces immuno-oncology startup with New Zealand university

By Lydia Coutre, Crain's Cleveland Business  |  January 18, 2017

BioMotiv, a Cleveland-based drug development accelerator associated with The Harrington Project, and a university in New Zealand have announced the formation of an immuno-oncology startup that will work to develop a suite of cancer vaccines.

Michigan Blues on path to slash expenses $300 million by 2019

By Jay Greene, Crain's Detroit Business  |  December 10, 2016

Blue Cross and Blue Shield of Michigan has cut expenses by $106.5 million since it announced its three-year strategic business transformation project in November 2015 and said it is on-pace to cut a total of $300 million by 2019.

AbbVie, Northwestern to collaborate on cancer research

By Kristen Schorsch, Crain's Chicago Business  |  December 10, 2016

Scientists at Northwestern's Lurie Cancer Center will be able to access new therapies developed by North Chicago-based AbbVie which can exclusively license any discoveries made during the collaboration.

Medicaid cancer patients receive subpar care

Medicaid cancer patients receive subpar care

By Virgil Dickson  |  December 07, 2016

Cancer patients with Medicaid coverage receive poorer quality and less healthcare than those with employer-sponsored, Medicare or other private insurance. Medicaid benefits vary from state by state and experts say that inequality will likely grow under the Trump administration.

Bringing world-class cancer care closer to home

Bringing world-class cancer care closer to home

By Elizabeth Whitman  |  November 26, 2016

Links between community hospitals and cancer centers can lead to better care and a better bottom line. Many regard these relationships as necessary to preserve quality and expand access to state-of-the-art oncology care.

Susan G. Komen's CEO is stepping down

By Modern Healthcare  |  November 17, 2016

Dr. Judith Salerno is stepping down as president and CEO of the breast cancer research group to pursue new opportunities. Susan G. Komen's general counsel, Ellen Wilmott, will step into the role on an interim basis.

Missouri tobacco tax initiatives ignite peculiar conflict

Missouri tobacco tax initiatives ignite peculiar conflict

By Modern Healthcare  |  November 12, 2016

A provision of Amendment 3 would have hurt Big Tobacco's smaller rivals by imposing an additional 67-cent-per-pack tax—on top of the 60-cent hike imposed on the major brands—on discount cigarette brands left out of a 1998 tobacco lawsuit settlement. In the settlement, the major tobacco...

Advertisement
X

Subscribe and SAVE over 72%

View our best offer
Subscribe to Print